Related Experiment Video
Updated: Jan 7, 2026
Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
PDCD4: A critical regulator in leukemic signaling networks and its therapeutic potential
Jiaying Huang1, Miao Yin1, Ran Zhang1
1Hunan Normal University Health Science Center, Hunan Normal University, Changsha, China.
Abstract:
Programmed cell death 4 (PDCD4) is a tumor suppressor characterized by its MA3 domain-mediated binding to eIF4A, which suppresses protein synthesis. Its primary functions include inhibiting cell proliferation, invasion, and metastasis, as well as promoting apoptosis. Leukemia is a clonally hematologic malignancy whose pathogenesis is driven primarily by the aberrant activation of key signaling pathways. These dysregulated signals promote enhanced self-renewal, uncontrolled proliferation, impaired differentiation, and blocked apoptosis, collectively arresting leukemic cells at various stages of development. Recent studies have demonstrated a close association between PDCD4 and leukemia development, indicating that PDCD4 regulates this process mainly by participating in abnormally activated signaling pathways. This review examines the expression and regulation of PDCD4 in leukemia, with a focus on its role as a molecular hub that connects the JAK/STAT, PI3K/AKT, and MAPK signaling pathways into a comprehensive network of leukemia pathways. Furthermore, the potential value of PDCD4 in the treatment of leukemia is discussed.
Insights
Programmed cell death 4 (PDCD4) is a tumor suppressor crucial in leukemia. This review explores PDCD4
Area of Science:
- Oncology
- Molecular Biology
- Hematology
Background:
- Programmed cell death 4 (PDCD4) functions as a tumor suppressor by inhibiting protein synthesis and promoting apoptosis.
- Leukemia pathogenesis involves aberrant signaling pathways leading to uncontrolled cell growth and survival.
- PDCD4's role in leukemia is increasingly recognized, particularly its involvement in dysregulated signaling networks.
Purpose of the Study:
- To review the expression and regulation of PDCD4 in leukemia.
- To elucidate PDCD4's function as a molecular hub connecting key leukemia signaling pathways.
- To discuss the therapeutic potential of PDCD4 in leukemia treatment.
Main Methods:
- Literature review focusing on PDCD4 expression, regulation, and function in leukemia.
- Analysis of PDCD4's interactions within JAK/STAT, PI3K/AKT, and MAPK signaling pathways.
- Synthesis of current research on PDCD4's role in leukemogenesis and its therapeutic implications.
Main Results:
- PDCD4 expression and regulation are altered in leukemia.
- PDCD4 acts as a central node integrating multiple oncogenic signaling pathways in leukemia.
- PDCD4 influences leukemic cell proliferation, apoptosis, and metastasis.
Conclusions:
- PDCD4 is a critical regulator in leukemia, linking key signaling pathways.
- Targeting PDCD4 may offer a novel therapeutic strategy for leukemia treatment.
- Further research into PDCD4's mechanisms in leukemia is warranted for clinical applications.
